{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T15:58:00Z","timestamp":1776614280140,"version":"3.51.2"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013795","name":"Fujian Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017543","name":"Fujian Medical University Provincial Clinical Medical College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.molimm.2022.12.008","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T05:47:04Z","timestamp":1671601624000},"page":"226-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Cancer\/testis antigen HEMGN correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma"],"prefix":"10.1016","volume":"153","author":[{"given":"Yingfeng","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingfeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanli","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianbin","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xunyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5334-1656","authenticated-orcid":false,"given":"Liangyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2022.12.008_bib1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.7150\/ijms.51297","article-title":"Heat shock factor 5 correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma","volume":"18","author":"Aizemaiti","year":"2021","journal-title":"Int. J. Med. Sci."},{"issue":"8","key":"10.1016\/j.molimm.2022.12.008_bib2","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/sj.leu.2403808","article-title":"High expression of EDAG and its significance in AML","volume":"19","author":"An","year":"2005","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.molimm.2022.12.008_bib3","first-page":"15","article-title":"Tumor microenvironment","volume":"56","author":"Arneth","year":"2019","journal-title":"Med. (Kaunas. )."},{"issue":"4","key":"10.1016\/j.molimm.2022.12.008_bib4","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","article-title":"Therapeutic targeting of the tumor microenvironment","volume":"11","author":"Bejarano","year":"2021","journal-title":"Cancer Discov."},{"issue":"8","key":"10.1016\/j.molimm.2022.12.008_bib5","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1158\/1078-0432.CCR-15-1399","article-title":"Dendritic cell-based immunotherapy: state of the art and beyond","volume":"22","author":"Bol","year":"2016","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.molimm.2022.12.008_bib6","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.lungcan.2017.08.005","article-title":"PD-L1 expression in advanced NSCLC: Insights into risk stratification and treatment selection from a systematic literature review","volume":"112","author":"Brody","year":"2017","journal-title":"Lung Cancer"},{"issue":"6206","key":"10.1016\/j.molimm.2022.12.008_bib7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1126\/science.1253462","article-title":"Spatial and temporal diversity in genomic instability processes defines lung cancer evolution","volume":"346","author":"de Bruin","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.molimm.2022.12.008_bib8","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.tranon.2018.04.006","article-title":"Immune prophets of lung cancer: the prognostic and predictive landscape of cellular and molecular immune markers","volume":"11","author":"Catacchio","year":"2018","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.molimm.2022.12.008_bib9","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/15384047.2016.1156259","article-title":"EDAG-1 promotes proliferation and invasion of human thyroid cancer cells by activating MAPK\/Erk and AKT signal pathways","volume":"17","author":"Chen","year":"2016","journal-title":"Cancer Biol. Ther."},{"issue":"3","key":"10.1016\/j.molimm.2022.12.008_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.350","article-title":"Landscape and dynamics of single tumor and immune cells in early and advanced-stage lung adenocarcinoma","volume":"11","author":"Chen","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.molimm.2022.12.008_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/bs.apcsb.2020.08.001","article-title":"Immunological and functional aspects of MAGEA3 cancer\/testis antigen","volume":"125","author":"Das","year":"2021","journal-title":"Adv. Protein Chem. Struct. Biol."},{"issue":"2","key":"10.1016\/j.molimm.2022.12.008_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41419-017-0063-y","article-title":"Cell death-based treatment of lung adenocarcinoma","volume":"9","author":"Denisenko","year":"2018","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.molimm.2022.12.008_bib13","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.molimm.2022.12.008_bib14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/08830185.2015.1018418","article-title":"Cancer-testis antigens and immunotherapy in the light of cancer complexity","volume":"34","author":"Grizzi","year":"2015","journal-title":"Int. Rev. Immunol."},{"issue":"10066","key":"10.1016\/j.molimm.2022.12.008_bib15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","article-title":"Lung cancer: current therapies and new targeted treatments","volume":"389","author":"Hirsch","year":"2017","journal-title":"Lancet"},{"issue":"10066","key":"10.1016\/j.molimm.2022.12.008_bib16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","article-title":"Lung cancer: current therapies and new targeted treatments","volume":"389","author":"Hirsch","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.molimm.2022.12.008_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw144","article-title":"Genomic analysis of immune cell infiltrates across 11 tumor types","volume":"108","author":"Iglesia","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.molimm.2022.12.008_bib18","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1182\/blood-2009-07-235341","article-title":"Hemgn is a direct transcriptional target of HOXB4 and induces expansion of murine myeloid progenitor cells","volume":"116","author":"Jiang","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.molimm.2022.12.008_bib19","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1080\/21645515.2019.1571892","article-title":"PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations","volume":"15","author":"Jiang","year":"2019","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.molimm.2022.12.008_bib20","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1186\/s12885-022-09930-5","article-title":"Cancer-testis antigen KK-LC-1 is a potential biomarker associated with immune cell infiltration in lung adenocarcinoma","author":"Kang","year":"2022","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.molimm.2022.12.008_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nri3789","article-title":"Immune cell promotion of metastasis","volume":"15","author":"Kitamura","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.molimm.2022.12.008_bib22","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/sj.cdd.4401490","article-title":"EDAG regulates the proliferation and differentiation of hematopoietic cells and resists cell apoptosis through the activation of nuclear factor-kappa B","volume":"11","author":"Li","year":"2004","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.molimm.2022.12.008_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118622","article-title":"Circ_PSD3 promotes the progression of papillary thyroid carcinoma via the miR-637\/HEMGN axis","volume":"264","author":"Li","year":"2021","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.molimm.2022.12.008_bib24","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/pmic.201200489","article-title":"Scanning of novel cancer\/testis proteins by human testis proteomic analysis","volume":"13","author":"Liu","year":"2013","journal-title":"Proteomics"},{"key":"10.1016\/j.molimm.2022.12.008_bib25","first-page":"1106","article-title":"MAGE-A1 in lung adenocarcinoma as a promising target of chimeric antigen receptor T cells","author":"Mao","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.molimm.2022.12.008_bib26","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.mcna.2018.12.006","article-title":"Lung cancer","volume":"103","author":"Nasim","year":"2019","journal-title":"Med. Clin. North Am."},{"issue":"9","key":"10.1016\/j.molimm.2022.12.008_bib27","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.tcb.2020.06.003","article-title":"The roles of CD8+ T cell subsets in antitumor immunity","volume":"30","author":"Paul","year":"2020","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.molimm.2022.12.008_bib28","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejca.2018.11.002","article-title":"Predictive biomarkers of response for immune checkpoint inhibitors in non-small-cell lung cancer","volume":"106","author":"Prelaj","year":"2019","journal-title":"Eur. J. Cancer"},{"issue":"11","key":"10.1016\/j.molimm.2022.12.008_bib29","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.molimm.2022.12.008_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.path.2019.11.002","article-title":"Targeted Therapy and Checkpoint Immunotherapy in Lung Cancer","volume":"13","author":"Ruiz-Cordero","year":"2020","journal-title":"Surg. Pathol. Clin."},{"issue":"1","key":"10.1016\/j.molimm.2022.12.008_bib31","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin"},{"key":"10.1016\/j.molimm.2022.12.008_bib32","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1158\/1078-0432.CCR-10-2805","article-title":", Prognostic immune markers in non-small cell lung cancer","volume":"17","author":"Suzuki","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.molimm.2022.12.008_bib33","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3389\/fimmu.2018.00947","article-title":"NY-ESO-1 based immunotherapy of cancer: current perspectives","volume":"9","author":"Thomas","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.molimm.2022.12.008_bib34","first-page":"883","article-title":"PD-1 and PD-L1 as immunotherapy targets and biomarkers in non-small cell lung cancer","volume":"24","author":"Tsoukalas","year":"2019","journal-title":"J. Buon."},{"key":"10.1016\/j.molimm.2022.12.008_bib35","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.2147\/OTT.S105862","article-title":"PD-L1 expression in human cancers and its association with clinical outcomes","volume":"9","author":"Wang","year":"2016","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.molimm.2022.12.008_bib36","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1634\/theoncologist.2019-IO-S1-s05","article-title":"PD-1\/PD-L1 blockade therapy in advanced non-small-cell lung cancer: current status and future directions","volume":"24","author":"Xia","year":"2019","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.molimm.2022.12.008_bib37","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/dvdy.10399","article-title":"Alternative promoters and polyadenylation regulate tissue-specific expression of Hemogen isoforms during hematopoiesis and spermatogenesis","volume":"228","author":"Yang","year":"2003","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.molimm.2022.12.008_bib38","article-title":"CD8+ T cell-associated gene signature correlates with prognosis risk and immunotherapy response in patients with lung adenocarcinoma","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2022.12.008_bib39","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.omtn.2020.07.024","article-title":"Multi-omics data analyses construct TME and identify the immune-related prognosis signatures in human LUAD","volume":"21","author":"Zhang","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.molimm.2022.12.008_bib40","article-title":"Hemgn protects hematopoietic stem and progenitor cells against transplantation stress through negatively regulating IFN-\u03b3 signaling","author":"Zhao","year":"2021","journal-title":"Adv. Sci. (Weinh. )"},{"issue":"5","key":"10.1016\/j.molimm.2022.12.008_bib41","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1159\/000479837","article-title":"High expression of AHSP, EPB42, GYPC and HEMGN predicts favorable prognosis in FLT3-ITD-negative acute myeloid leukemia","volume":"42","author":"Zhu","year":"2017","journal-title":"Cell Physiol. Biochem."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589022004989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589022004989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:45:20Z","timestamp":1758980720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589022004989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":41,"alternative-id":["S0161589022004989"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2022.12.008","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer\/testis antigen HEMGN correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2022.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}